12/10
11:20 am
iron
Rating for IRON
Medium
Report
Rating for IRON
12/9
06:22 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock.
12/9
06:22 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock.
12/9
08:11 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $118.00 price target on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $118.00 price target on the stock.
11/13
12:45 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock, up previously from $75.00.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock, up previously from $75.00.
11/13
12:45 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock, up previously from $75.00.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $83.00 price target on the stock, up previously from $75.00.
11/5
06:48 pm
iron
Rating for IRON
Medium
Report
Rating for IRON
11/5
06:48 pm
iron
Rating for IRON
Medium
Report
Rating for IRON
11/5
09:43 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
High
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
11/5
07:30 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $85.00 price target on the stock.
High
Report
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $85.00 price target on the stock.
11/5
07:30 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $85.00 price target on the stock.
High
Report
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $85.00 price target on the stock.
11/4
10:47 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $75.00 price target on the stock, up previously from $60.00.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $75.00 price target on the stock, up previously from $60.00.
11/4
10:47 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $75.00 price target on the stock, up previously from $60.00.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $75.00 price target on the stock, up previously from $60.00.
11/4
09:42 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $110.00 price target on the stock, up previously from $66.00.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $110.00 price target on the stock, up previously from $66.00.
11/4
09:42 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $110.00 price target on the stock, up previously from $66.00.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $110.00 price target on the stock, up previously from $66.00.
10/28
08:25 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
10/23
06:50 am
iron
Rating for IRON
Medium
Report
Rating for IRON
10/23
06:50 am
iron
Rating for IRON
Medium
Report
Rating for IRON
10/16
11:03 am
iron
Rating for IRON
Low
Report
Rating for IRON
10/16
11:03 am
iron
Rating for IRON
Low
Report
Rating for IRON
10/16
08:44 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:44 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/15
11:10 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $85.00 price target on the stock.
Low
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $85.00 price target on the stock.
10/15
11:08 am
iron
Rating for IRON
Low
Report
Rating for IRON